What’s New at DiaPharma?

Posted: October 25, 2021

It’s Not Just Support. It’s Solutions.


diapharma

Staff Spotlight

Meet Nancy, Executive Assistant

We’re excited to welcome Nancy to the DiaPharma team. Nancy writes, “I was born in Farmington Hills Michigan. I have three children; my youngest daughter Brenna is still at home while attending University of Cincinnati. I have been with my husband Tim for 16 years now, and we’ve been married for two years. We have two dogs: Henry a Black Lab / Dachshund, and our newest addition is Zoe, a Beagle mix. My husband and I enjoy spending time together at home and with our grandchildren, Dean, 7 and Tala, 3.

I wasn’t looking for a job at the time, but a recruiter who I have worked with in the past called me about an opportunity with DiaPharma, and I was intrigued. After speaking with Amy and Madeleine via Zoom, I knew that I had found something amazing and was thrilled when I was offered the position. The best thing about DiaPharma is the attitude of the employees and the amount of time they have worked here! It says a lot of the management and the structure of the company!”

liver disease research Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI)

liver disease research Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI)

Product Spotlight

DiaPharma has the tools for your liver disease research: Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI).

Measure apoptosis and total cell death with our cytokeratin 18/Keratin 18 (CK18/K18) biomarkers:

  • M30 Apoptosense® ccK18 ELISA
  • M65® ELISA K18 ELISA
  • M65® EpiDeath® ELISA

Additional Biomarkers of Interest:

  • Osteopontin (OPN)
  • Soluble CD163 (sCD163)
  • Complement Factors 3a/5a/C5b-9

Visit diapharma.com for our comprehensive portfolio.

All products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.

complement biomarker assays

liver disease research Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI)

diapharma

Mechanistic Biomarkers in Drug Development
FATTY LIVER DISEASE
FATTY LIVER
DISEASE
DILI / TOXICOLOGY
DILI /
TOXICOLOGY
CANCER RESEARCH
CANCER
RESEARCH
HEMOSTASIS
HEMOSTASIS

It’s Not Just Support. It’s Solutions.

Over 20 years of scientific expertise, with support just a call or click away.

diapharma bioassays

diapharma

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846

ML-00-00863Rev01